Ignite Creation Date:
2024-05-06 @ 2:15 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04252768
Status:
WITHDRAWN
Last Update Posted:
2023-03-22
First Post:
2020-01-29
Brief Title:
A Study in Hormone Receptor-positive Metastatic Breast Carcinoma Patients to Test a New Schedule of Efti IMP321 Eftilagimod Alpha as Adjunctive to a Weekly Treatment Regimen of Paclitaxel
Sponsor:
Immutep SAS
Organization:
Immutep SAS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-29
First Submit QC Date:
January 31 2020
Study First Post Date:
2020-02-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-20
Last Update Post Date:
2023-03-22
Last Update Post Date Type:
ACTUAL